Project Grant R21EB038494
- Federal Grant Award Summary Massachusetts General Hospital received a $165,000 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) for a two-year project period beginning August 1, 2025 and concluding July 31, 2027. The award supports research focused on modeling and safety assessment of magnetic spinal cord stimulation (MSCS), an...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Massachusetts General Hospital a $269,460 Project Grant effective August 1, 2025 through July 31, 2027 under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award supports the development of advanced magnetic resonance imaging (MRI) acquisition and analysis methods that combine diffusion-relaxometry...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Massachusetts General Hospital $656,750 through the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) on August 1, 2025, for a three-year project period concluding July 31, 2028. The award funds research to develop and optimize Electrical Impedance Tomography (EIT) as a bedside imaging tool for assessing lung perfusion in acute...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Massachusetts General Hospital a Project Grant of $622,804 on June 2, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The grant supports the development of quantitative point-of-care magnetic resonance imaging (MRI) technology for breast cancer screening. The project addresses limitations of current screening...
- Federal Project Grant Award Summary Massachusetts General Hospital (The General Hospital Corporation) received a $199,616 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective May 1, 2026 through April 30, 2028. The project develops a novel deep learning methodology for multi-modal biomedical data fusion that integrates three...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded the Trustees of Boston University a Project Grant of $613,124 under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) for the period August 15, 2025, through July 31, 2028. The project delivers the development and demonstration of Quantitative Phase Imaging Meta-Sensors (PIMSs)—advanced optical imaging sensors that...
- Federal Project Grant Award Summary Massachusetts General Hospital (The General Hospital Corporation) received a $357,712 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under CFDA 93.286 (Discovery and Applied Research for Technological Innovations to Improve Human Health), awarded September 1, 2025, with completion scheduled for August 31, 2027. This secondary analysis project will develop an interpretable and predictive machine learning model for...
- Federal Project Grant Award Summary Massachusetts General Hospital has received a $243,192 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) effective November 1, 2025, with completion targeted for April 30, 2028. The project, "Investigating the Role of Wnt Signaling in the Mechanical Maturation of Tendon," will deliver research services...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Massachusetts General Hospital a project grant of $346,427 on September 15, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to conduct TRUST CORODECT, a longitudinal imaging study examining the effects of urate-lowering therapy on vascular monosodium urate (MSU) deposits. This ancillary study to the larger TRUST clinical trial will...
- Federal Grant Award Summary The Trustees of Boston University received a $1.19 million Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award, obligated on August 1, 2025, with a completion date of April 30, 2029, supports research and development of handheld spatial frequency domain imaging (SFDI) technology using spiral illumination...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Massachusetts General Hospital (MGH) a Project Grant totaling $206,250 on June 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The project, titled "Integrated Mechano-Arthroscope for Minimally Invasive Assessment of Joint Pathologies," aims to develop and validate a novel diagnostic device that directly measures the mechanical properties of joint tissues such as cartilage and meniscus. The integrated mechano-arthroscope will enable orthopedic surgeons to assess the functional mechanical integrity of joint tissues during surgical procedures, addressing a critical gap in current diagnostic approaches that rely on structural imaging and visual assessment but do not provide direct mechanical quality measurements. This research addresses a significant clinical need in the treatment of degenerative joint disease (arthritis), a condition affecting over 500 million people globally. By providing real-time mechanical assessment capabilities during arthroscopy, the technology will support improved surgical decision-making, tissue repair monitoring, and evaluation of treatment effectiveness in living patients. The three-year project period extends from June 1, 2026 through May 31, 2029, and is being conducted at MGH's Research Management Division in Boston, Massachusetts.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $206.3k | 6/3/26 |